您的位置: 首页 > 农业专利 > 详情页

NOVEL FUNCTIONALLY ENHANCED MESENCHYMAL PROGENITOR CELLS CELL THERAPEUTIC COMPOSITION FOR REVASCULARIZATION OR PREVENTING VASCULAR DAMAGE INCLUDING THE SAME AND METHOD FOR PREPARING THE SAME
专利权人:
MIRAECELLBIO. CO., LTD.;MIRAECELLBIO. CO.; LTD.;주식회사 미래셀바이오
发明人:
CHUNG HYUNG MIN,정형민,HONG KI SUNG,홍기성,SHIN JEONG MIN,신정민
申请号:
KR1020170153113
公开号:
KR1020180063817A
申请日:
2017.11.16
申请国别(地区):
KR
年份:
2018
代理人:
摘要:
One embodiment of the present invention provides a cell therapeutic composition for revascularization or vascular damage prevention, which comprises mesenchymal progenitors as an active ingredient, wherein the mesenchymal progenitors express epidermal growth factor receptors (EGF-R) at a higher level than mesenchymal stem cells (MSC) and express cluster differentiation 95 (CD95) at a lower level than mesenchymal stem cells.본 발명의 일 실시예는 중간엽 줄기세포(MSC, Mesenchymal Stem Cell)에 비해 표피성장인자 수용체(EGF-R, Epidermal Growth Factor Receptor)를 과발현하고, 중간엽 줄기세포에 비해 CD95(Cluster Differentiation 95)를 저발현하는 간엽성 전구세포(Mesenchymal Progenitor)를 유효성분으로 포함하는, 혈관 재생용 또는 혈관 손상 방지용 세포치료제 조성물을 제공한다.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充